ResearcherUniversity of MiamiNo recent work listed
Prateek Sharma MD
Matched on ORCID iD 0000-0003-4695-8698; OpenAlex author ID A5100718227. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2020: 1 paper · 2021: 2 papers · 2022: 3 papers · 2023: 1 paper
Papers 7
- Global trends in the incidence and mortality of pancreatic cancer based on geographic location, socioeconomic status, and demographic shift. Co-author DOI 10.1002/jso.27462↗
- Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. First author DOI 10.1016/j.hpb.2022.05.003↗
- Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer. Co-author DOI 10.1038/s41388-022-02368-w↗
- Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy resp… Co-author DOI 10.7554/elife.78921↗
- An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. Co-author DOI 10.1007/s11605-020-04681-9↗
- Hsp70 modulates immune response in pancreatic cancer through dendritic cells. First author DOI 10.1080/2162402x.2021.1976952↗
- Symphony in chaos: Immune orchestra during pancreatic cancer progression. Co-author DOI 10.1016/j.ebiom.2020.102787↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Vrishketan Sethi · 4 shared papers, 2020–2022 · strength 0.51
- Paper Symphony in chaos: Immune orchestra during pancreatic cancer progression. DOI 10.1016/j.ebiom.2020.102787↗
- Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Tejeshwar Jain · 4 shared papers, 2020–2022 · strength 0.51
- Paper Symphony in chaos: Immune orchestra during pancreatic cancer progression. DOI 10.1016/j.ebiom.2020.102787↗
- Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Vikas Dudeja · 4 shared papers, 2020–2022 · strength 0.51
- Paper Symphony in chaos: Immune orchestra during pancreatic cancer progression. DOI 10.1016/j.ebiom.2020.102787↗
- Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Nipun B. Merchant · 4 shared papers, 2021–2022 · strength 0.50
- Paper Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphoc… DOI 10.7554/elife.78921↗
- Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
- Paper Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53… DOI 10.1038/s41388-022-02368-w↗
- Jashodeep Datta · 3 shared papers, 2022 · strength 0.39
- Paper Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphoc… DOI 10.7554/elife.78921↗
- Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
- Paper Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53… DOI 10.1038/s41388-022-02368-w↗
- Siddharth Mehra · 3 shared papers, 2021–2022 · strength 0.36
- Paper Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphoc… DOI 10.7554/elife.78921↗
- Paper Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53… DOI 10.1038/s41388-022-02368-w↗
- Paper Hsp70 modulates immune response in pancreatic cancer through dendritic cells. DOI 10.1080/2162402x.2021.1976952↗
- Bhuwan Giri · 3 shared papers, 2021–2022 · strength 0.35
- Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Paper Hsp70 modulates immune response in pancreatic cancer through dendritic cells. DOI 10.1080/2162402x.2021.1976952↗
- Chandrakanth Are · 1 shared paper, 2023 · strength 0.26
- Iago De Castro Silva · 2 shared papers, 2022 · strength 0.26
- Paper Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphoc… DOI 10.7554/elife.78921↗
- Paper Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53… DOI 10.1038/s41388-022-02368-w↗
- Nilesh Deshpande · 2 shared papers, 2022 · strength 0.26
- Paper Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphoc… DOI 10.7554/elife.78921↗
- Paper Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53… DOI 10.1038/s41388-022-02368-w↗
- Peter J. Hosein · 2 shared papers, 2022 · strength 0.26
- Paper Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphoc… DOI 10.7554/elife.78921↗
- Paper Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53… DOI 10.1038/s41388-022-02368-w↗
- Utpreksha Vaish · 2 shared papers, 2021–2022 · strength 0.23
- Srikanth Iyer · 2 shared papers, 2021–2022 · strength 0.23
- Sundaram Ramakrishnan · 2 shared papers, 2021 · strength 0.22
- Harrys K.C. Jacob · 2 shared papers, 2021 · strength 0.22
- Anthony R. Ferrantella · 2 shared papers, 2021 · strength 0.22
- Ashok Kumar Saluja · 2 shared papers, 2021 · strength 0.22
- Jonathan S. England · 1 shared paper, 2022 · strength 0.14
- John Bart Rose · 1 shared paper, 2022 · strength 0.13
- Sushanth Reddy · 1 shared paper, 2022 · strength 0.13
- Suresh T. Chari · 1 shared paper, 2022 · strength 0.13
- Christine Isabelle Rafie · 1 shared paper, 2022 · strength 0.12
- Austin R. Dosch · 1 shared paper, 2022 · strength 0.12
- Samara P. Singh · 1 shared paper, 2022 · strength 0.12
- Nagaraj S. Nagathihalli · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.